Abstract 4365718: Artificial Intelligence–Enabled Electrocardiography for Detecting Risk of Rehospitalization in patients with Heart Failure
Abstract
Background: Preventing and managing hospital readmissions is critical in heart failure (HF) care, yet conventional monitoring tools have limitations. While artificial intelligence-enabled electrocardiograms (AI-ECGs) show promise in detecting cardiac dysfunction, little is known about their post-discharge score dynamics in HF patients. Hypothesize: We hypothesized that AI-enabled ECG scores would show distinct temporal patterns after hospital discharge in patients with HF, and that these patterns would differ between patients who experienced rehospitalization and those who did not. Method: This single-center retrospective study analyzed ECG data from patients hospitalized for HF between March 2017 and January 2025 in South Korea. Post-discharge, ECGs were processed using AI-ECG models for left ventricular systolic dysfunction (LVSD), diastolic dysfunction (LVDD), and myocardial infarction (MI). We compared AI-ECG patterns in patients readmitted within six months vs. those not (Figure 1). Temporal trends in AI-ECG scores were assessed using a mixed-effects linear regression model with group and time as fixed effects, and patient as a random effect. Result: Among 1,007 patients, 1,539 hospitalization events were identified. A total of 1,674 ECGs from 269 rehospitalized and 4,066 ECGs from 917 non-rehospitalized patients were collected from 180 days before to 60 days after the index readmission or follow-up end. The mean age was 65.2 years, and 63.1% were male. Diabetes mellitus and chronic kidney disease were significantly more prevalent in the rehospitalization group, whereas other comorbidities were comparable. Significant differences in ECG intervals and axes were also observed, with no notable difference in heart rate. In the LVSD model, rehospitalized patients showed higher scores overall (β = 7.96, 95% CI: 3.18–12.75, p = 0.001) (Figure 2). Time since discharge was associated with decreasing scores (β = –0.096/day, 95% CI: –0.104 to –0.087, p<0.001), but this decline was attenuated in the rehospitalization group (interaction β = 0.092, 95% CI: 0.069–0.115, p<0.001). The LVDD model demonstrated a similar trend, while the MI model exhibited no statistically significant differences in scores (Figure 3). Conclusion: AI-ECG models show potential as dynamic biomarkers for detecting early physiological deterioration and predicting readmission risk in HF patients. These findings support their use in future patient monitoring strategies.
Article Details
Authors (7)
Ga In Han
Medical AI Co., Ltd, Seoul, Korea (the Republic of)
Hak Seung Lee
Sora Kang
Ah-Hyun Yoo
Medical AI Co., Ltd, Seoul, Korea (the Republic of)
Min Sung Lee
Jeong Min Son
Kyung-Hee Kim
Research Institute, National Cancer Center